Discontinued — last reported Q1 '19
Business Segments · Income Loss From Equity Method Investments
European Pharmaceutical Solutions — Income Loss From Equity Method Investments
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ2 2016
Last reportedQ1 2019
Rolls up toEquity Method Income
How to read this metric
An increase represents growing profitability from strategic partnerships, while a decrease or loss indicates underperformance of these equity-accounted entities.
Detailed definition
This metric captures the company's proportional share of net income or loss from investments in European pharmaceutical...
Peer comparison
Comparable to 'Equity in earnings of unconsolidated affiliates' reported by other multinational healthcare and distribution firms.
Metric ID:
mck_segment_european_pharmaceutical_solutions_income_loss_from_equity_method_investmentsSimilar Metrics at Other Companies
Frequently Asked Questions
- What does european pharmaceutical solutions — income loss from equity method investments mean?
- The company's share of profits or losses from its non-controlled European business partnerships.